Navigation Links
Orexigen(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2009 Financial Results
Date:3/9/2010

hase 2b clinical trial of Empatic.  The results of this trial demonstrated the following:

  • Patients completing 24 weeks of Empatic360 (bupropion SR 360mg/zonisamide SR 360 mg) therapy lost 9.9% of their baseline body weight compared to 1.7% for placebo patients (p<0.001).  Importantly, mean weight loss for patients on Empatic continued to decline through the endpoint of the trial, with no evidence of a weight loss plateau.  
  • Improvements were observed in key markers of cardiometabolic risk, such as waist circumference, triglycerides, fasting insulin and blood pressure, compared to placebo.  
  • The most commonly reported adverse events, as well as those leading to discontinuation, for all Empatic patients were headache, nausea and insomnia.  Adverse events and laboratory findings appeared to be consistent with the individual components of Empatic.  There were no statistically or clinically meaningful differences between Empatic and placebo on measures of cognitive function, depression, suicidality or anxiety.

Corporate

  • In July, the C
    '/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging ... China,s orthopedic instrument industry has seen rapid ... from 3.28 billion yuan in 2006 to 9.85 billion ...
(Date:1/15/2014)... Foundation today announced it has established a relief fund ... weather that has gripped much of the nation. AARP and ... to support these emergency relief efforts AARP and AARP Foundation ... up to $500,000 in aid. The matching program will be ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces ... condition to the announced tender offer for all of the outstanding ... result of the waiver, the transaction is no longer conditional on ... January 24, 2014 following the currently scheduled expiration time, subject to ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... TEL AVIV, Israel, August 23, 2011 Elbit Imaging ... " Company " ) (NASDAQ: EMITF) , announced today, ... Series B Notes of the Company, that the interest rate borne by ... and ending on February 21, 2012 is 1.56055%. About Elbit ...
... Aug. 23, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain ... the largest drugstore chain in China based on the ... board of directors has authorized a share repurchase program. ... may repurchase up to US$20 million worth of its ...
Cached Medicine Technology:Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes 2Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes 3China Nepstar Chain Drugstore Announces Share Repurchase Program 2China Nepstar Chain Drugstore Announces Share Repurchase Program 3
(Date:4/17/2014)... (April 17, 2014) Doctors who treat patients ... lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision. ... the disease and help relieve shortness of breath. ... and sirolimus can cause potentially fatal complications following ... Dr. Daniel Dilling, medical director of Loyola University ...
(Date:4/17/2014)... 17, 2014 By discovering a new mechanism that ... stroke, researchers at UC Irvine and the Salk Institute ... limit or prevent stroke-induced brain damage. , A complex ... of death and primary reason for disability in the ... stroke and lets blood-borne material into the brain, causing ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
(Date:4/17/2014)... April 17, 2014 Meaningful long-term survival ... cancer of the abdomen when treated with cytoreductive ... to a first-of-its-size analysis by physicians at Wake ... has the largest reported, single-center experience with cytoreductive ... Levine, M.D., and analysis of 20 years, worth ...
(Date:4/17/2014)... 94 per cent of Canadians surveyed said they would ... a specific number of genetic conditions, only 80 per ... screening that would sequence their newborns, genomes.,Most newborns in ... first day or two of life in which a ... and tested for about five to 54 conditions, depending ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Internet use may cut retirees' depression 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3
... provides clues to variations in disease progression , FRIDAY, Sept. ... linked to improvements in the body,s ability to repair itself ... treatments, a U.S. scientist reports. , "Most MS genetic studies ... get MS and others do not," study author Allan Bieber, ...
... Mandatory alcohol testing programs for truck and bus drivers ... in fatal crashes, according to a new study by ... the Johns Hopkins Bloomberg School of Public Health. ... carrier (heavy trucks and buses) drivers and over 83,000 ...
... ... online retailing guide "Internet Retailer". The news story was published on August 7th, 2009 and ... ... Retailer for 40% growth despite doing away with paid searches. The news story sites a ...
... , IRVING, Texas, Sept. 11 ... 643 on its third annual Inc. 5000, an exclusive ranking ... most comprehensive look at the most important segment of the ... rental car service Zipcar, and beverage maker Honest Tea are ...
... GREENSBORO, N.C., Sept. 11 Merz Pharmaceuticals, ... the U.S. Food and Drug Administration (FDA) has accepted ... Balance. , , Belotero(R) Balance ... that utilizes a cohesive polydensified matrix (CPM(TM)) technology. This ...
... , Office Equipment Manufacturers gain Access to Indoor ... 11 Atlanta-based indoor air quality (IAQ) firm, Air Quality Sciences ... States to perform office equipment emissions testing for Germany,s Blue Angel ... in the world. AQS successfully completed rigorous proficiency verification to ...
Cached Medicine News:Health News:Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes 2Health News:40% Revenue Growth Nets My1Stop.com a Featured News Story in "Internet Retailer" 2Health News:SoftLight Development, Inc. Ranks No. 643 on the 2009 Inc. 5000 with Three-Year Sales Growth of 429.7% 2Health News:SoftLight Development, Inc. Ranks No. 643 on the 2009 Inc. 5000 with Three-Year Sales Growth of 429.7% 3Health News:SoftLight Development, Inc. Ranks No. 643 on the 2009 Inc. 5000 with Three-Year Sales Growth of 429.7% 4Health News:SoftLight Development, Inc. Ranks No. 643 on the 2009 Inc. 5000 with Three-Year Sales Growth of 429.7% 5Health News:SoftLight Development, Inc. Ranks No. 643 on the 2009 Inc. 5000 with Three-Year Sales Growth of 429.7% 6Health News:SoftLight Development, Inc. Ranks No. 643 on the 2009 Inc. 5000 with Three-Year Sales Growth of 429.7% 7Health News:Merz Pharmaceuticals' Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA 2Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 2Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 3
... helping you use technology that improves patient ... wireless, simple-to-use BD.id Patient Identification System for ... patient, the specimen container, and the order ... labels only for specimens actually collected, with ...
... Specimen Collections, a Cerner point-of-care solution, ... identification and collection. The solution enhances ... specimen collections process by employing bar-code ... information system integration to prevent potential ...
... CareChek SP Specimen Collection ... Windows CE Pocket PC ... (to perform positive patient ... and an HL7 interface ...
... newest Mediware product, which serves as ... produces a dynamic and complete representation ... clinician orders, medication list, allergies, and ... alerts that increase patient safety. MediMAR ...
Medicine Products: